Beauty Health (NASDAQ:SKIN) vs. Nemaura Medical (NASDAQ:NMRD) Head to Head Analysis

Beauty Health (NASDAQ:SKIN) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.

Analyst Recommendations

This is a summary of current ratings for Beauty Health and Nemaura Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1	3	1	0	2.00
Nemaura Medical	0	0	0	0	0.00

Beauty Health currently has a consensus price target of $2.55, suggesting a potential upside of 80.21%. Given Beauty Health’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Beauty Health is more favorable than Nemaura Medical.

Volatility and Risk

Beauty Health has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500.

Insider & Institutional Ownership

93.3% of Beauty Health shares are held by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are held by institutional investors. 41.0% of Beauty Health shares are held by insiders. Comparatively, 40.4% of Nemaura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Beauty Health and Nemaura Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$347.62 million	0.51	-$100.12 million	($0.42)	-3.37
Nemaura Medical	$3,017.00	0.00	-$14.14 million	($0.39)	N/A

Nemaura Medical has lower revenue, but higher earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Nemaura Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Beauty Health and Nemaura Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Beauty Health	-8.11%	-44.83%	-3.54%
Nemaura Medical	N/A	N/A	N/A

Summary

Beauty Health beats Nemaura Medical on 7 of the 12 factors compared between the two stocks.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

About Nemaura Medical

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.